These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 21079748)

  • 1. Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.
    González-Hernández T; Cruz-Muros I; Afonso-Oramas D; Salas-Hernandez J; Castro-Hernandez J
    Front Neuroanat; 2010; 4():140. PubMed ID: 21079748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update.
    Brichta L; Greengard P
    Front Neuroanat; 2014; 8():152. PubMed ID: 25565977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The substantia nigra and ventral tegmental dopaminergic neurons from development to degeneration.
    Fu Y; Paxinos G; Watson C; Halliday GM
    J Chem Neuroanat; 2016 Oct; 76(Pt B):98-107. PubMed ID: 26859066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does altering proteasomal activity and trafficking reduce the arborization mediated specific vulnerability of SNpc dopaminergic neurons of Parkinson's disease?
    Bhaskar S; Gowda J; Prasanna J; Kumar A
    Med Hypotheses; 2020 Oct; 143():110062. PubMed ID: 32652429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular heterogeneity in the substantia nigra: A roadmap for understanding PD motor pathophysiology.
    Gaertner Z; Azcorra M; Dombeck DA; Awatramani R
    Neurobiol Dis; 2022 Dec; 175():105925. PubMed ID: 36372290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related changes in dopamine transporters and accumulation of 3-nitrotyrosine in rhesus monkey midbrain dopamine neurons: relevance in selective neuronal vulnerability to degeneration.
    Kanaan NM; Kordower JH; Collier TJ
    Eur J Neurosci; 2008 Jun; 27(12):3205-15. PubMed ID: 18598263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Zhang J; Yang B; Sun H; Zhou Y; Liu M; Ding J; Fang F; Fan Y; Hu G
    Neurosci Lett; 2016 Feb; 614():7-15. PubMed ID: 26748031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective increase of in vivo firing frequencies in DA SN neurons after proteasome inhibition in the ventral midbrain.
    Subramaniam M; Kern B; Vogel S; Klose V; Schneider G; Roeper J
    Eur J Neurosci; 2014 Sep; 40(6):2898-909. PubMed ID: 25059097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype, compartmental organization and differential vulnerability of nigral dopaminergic neurons.
    González-Hernández T; Afonso-Oramas D; Cruz-Muros I
    J Neural Transm Suppl; 2009; (73):21-37. PubMed ID: 20411765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.
    Martín-Bastida A; Lao-Kaim NP; Roussakis AA; Searle GE; Xing Y; Gunn RN; Schwarz ST; Barker RA; Auer DP; Piccini P
    Brain; 2019 Jul; 142(7):2023-2036. PubMed ID: 31056699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture.
    Kostuk EW; Cai J; Iacovitti L
    Glia; 2019 Aug; 67(8):1542-1557. PubMed ID: 31025779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related accumulation of Marinesco bodies and lipofuscin in rhesus monkey midbrain dopamine neurons: relevance to selective neuronal vulnerability.
    Kanaan NM; Kordower JH; Collier TJ
    J Comp Neurol; 2007 Jun; 502(5):683-700. PubMed ID: 17436290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease.
    Huddleston DE; Langley J; Sedlacik J; Boelmans K; Factor SA; Hu XP
    Hum Brain Mapp; 2017 May; 38(5):2627-2634. PubMed ID: 28240402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.
    González-Hernández T; Barroso-Chinea P; Rodríguez M
    Mov Disord; 2004 Sep; 19(9):1029-1042. PubMed ID: 15372592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson's disease.
    Kostuk EW; Cai J; Iacovitti L
    J Neuroinflammation; 2018 May; 15(1):139. PubMed ID: 29751760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's disease.
    Cai H; Liu G; Sun L; Ding J
    Transl Neurodegener; 2014; 3():27. PubMed ID: 25705376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
    Masilamoni GJ; Groover O; Smith Y
    Neurobiol Dis; 2017 Apr; 100():9-18. PubMed ID: 28042095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons.
    Masi A; Narducci R; Resta F; Carbone C; Kobayashi K; Mannaioni G
    Eur J Neurosci; 2015 Nov; 42(9):2699-706. PubMed ID: 26354486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
    Shin E; Rogers JT; Devoto P; Björklund A; Carta M
    Exp Neurol; 2014 Jul; 257():25-38. PubMed ID: 24747357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.